Blair William & CO Aclaris Therapeutics, Inc. Transaction History

Blair William & CO

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$9.74 - $17.92 $124,672 - $229,376	-12,800 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$12.27 - $18.49 $33,742 - $50,847	2,750 Added 27.36%	12,800 $186,000
Q3 2021 Nov 12, 2021	BUY	$13.38 - $18.8 $134,469 - $188,940	10,050 New	10,050 $181,000
Q2 2020 Aug 12, 2020	SELL	$1.04 - $1.73 $11,024 - $18,338	-10,600 Closed	0 $0
Q1 2020 May 11, 2020	SELL	$0.75 - $2.18 $6,054 - $17,596	-8,072 Reduced 43.23%	10,600 $11,000
Q4 2019 Feb 13, 2020	SELL	$1.02 - $1.97 $2,580 - $4,984	-2,530 Reduced 11.93%	18,672 $35,000
Q3 2019 Nov 12, 2019	SELL	$0.79 - $2.47 $30,952 - $96,774	-39,180 Reduced 64.89%	21,202 $23,000
Q2 2019 Aug 13, 2019	BUY	$2.13 - $7.06 $20,716 - $68,665	9,726 Added 19.2%	60,382 $132,000
Q1 2019 May 14, 2019	SELL	$5.63 - $7.84 $34,185 - $47,604	-6,072 Reduced 10.7%	50,656 $303,000
Q4 2018 Feb 14, 2019	BUY	$6.3 - $15.4 $72,891 - $178,178	11,570 Added 25.62%	56,728 $419,000
Q3 2018 Nov 13, 2018	SELL	$14.38 - $20.89 $638,428 - $927,453	-44,397 Reduced 49.58%	45,158 $656,000
Q2 2018 Aug 13, 2018	BUY	$16.46 - $20.33 $813,601 - $1 Million	49,429 Added 123.18%	89,555 $1.79 Million
Q1 2018 May 15, 2018	SELL	$17.08 - $25.64 $90,882 - $136,430	-5,321 Reduced 11.71%	40,126 $703,000
Q4 2017 Feb 14, 2018	BUY	$21.47 - $27.8 $665,033 - $861,105	30,975 Added 214.03%	45,447 $1.12 Million
Q3 2017 Nov 13, 2017	BUY	$23.02 - $28.8 $333,145 - $416,793	14,472	14,472 $374,000

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $242M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

Stay updated on Blair William & CO with notifications on news.